(Q37758473)

22 August 2017

1 reference

title

Update on anticonvulsant drugs (English)

1 reference

22 August 2017

Derek J Chong

1

1 reference

22 August 2017

Carl W Bazil

series ordinal

2

1 reference

22 August 2017

publication date

1 July 2010

1 reference

Current Neurology and Neuroscience Reports

22 August 2017

published in

1 reference

22 August 2017

volume

10

1 reference

22 August 2017

issue

4

1 reference

22 August 2017

page(s)

308-318

1 reference

https://scigraph.springernature.com/pub.10.1007/s11910-010-0120-8

22 August 2017

exact match

0 references

cites work

Positive and negative psychotropic effects of levetiracetam

1 reference

12 December 2020

Effects of antiepileptic drugs on lipids, homocysteine, and C-reactive protein

1 reference

12 December 2020

Cross-sensitivity of skin rashes with antiepileptic drug use.

1 reference

12 December 2020

1 reference

12 December 2020

Lamotrigine extended-release as adjunctive therapy for partial seizures

1 reference

12 December 2020

Effectiveness of first antiepileptic drug.

1 reference

12 December 2020

Comparison and predictors of rash associated with 15 antiepileptic drugs

1 reference

12 December 2020

Rufinamide for the adjunctive treatment of partial seizures in adults and adolescents: a randomized placebo-controlled trial

1 reference

12 December 2020

Successful treatment for refractory convulsive status epilepticus by non-parenteral lacosamide

1 reference

12 December 2020

Pregnancy outcomes in women with epilepsy: a systematic review and meta-analysis of published pregnancy registries and cohorts

1 reference

12 December 2020

Review of levetiracetam, with a focus on the extended release formulation, as adjuvant therapy in controlling partial-onset seizures

1 reference

12 December 2020

Retrospective analysis of 32 pediatric patients with anticonvulsant hypersensitivity syndrome (ACHSS).

1 reference

12 December 2020

Levetiracetam extended release and levetiracetam immediate release as adjunctive treatment for partial-onset seizures: an indirect comparison of treatment-emergent adverse events using meta-analytic techniques

1 reference

12 December 2020

A prospective study of cognitive fluency and originality in children exposed in utero to carbamazepine, lamotrigine, or valproate monotherapy

1 reference

12 December 2020

A randomised controlled trial examining the longer-term outcomes of standard versus new antiepileptic drugs. The SANAD trial

1 reference

12 December 2020

Juvenile myoclonic epilepsy: a 5-year prospective study

1 reference

12 December 2020

The first line of therapy in a girl with juvenile myoclonic epilepsy: should it be valproate or a new agent?

1 reference

12 December 2020

Effects of levetiracetam on chronic pain in multiple sclerosis: results of a pilot, randomized, placebo-controlled study.

1 reference

12 December 2020

Efficacy and tolerability of the new antiepileptic drugs I: treatment of new onset epilepsy: report of the Therapeutics and Technology Assessment Subcommittee and Quality Standards Subcommittee of the American Academy of Neurology and the [...]

1 reference

12 December 2020

The SANAD study of effectiveness of carbamazepine, gabapentin, lamotrigine, oxcarbazepine, or topiramate for treatment of partial epilepsy: an unblinded randomised controlled trial

1 reference

12 December 2020

Clinicopathological features and prognosis of drug rash with eosinophilia and systemic symptoms: a study of 30 cases in Taiwan.

1 reference

12 December 2020

Effectiveness and tolerability of rufinamide in children and adults with refractory epilepsy: first European experience

1 reference

12 December 2020

Once-daily extended-release levetiracetam as adjunctive treatment of partial-onset seizures in patients with epilepsy: a double-blind, randomized, placebo-controlled trial

1 reference

12 December 2020

The use of monotherapy in patients with epilepsy: an appraisal of the new antiepileptic drugs

1 reference

12 December 2020

Position statement on the coverage of anticonvulsant drugs for the treatment of epilepsy

1 reference

12 December 2020

Efficacy and safety of oral lacosamide as adjunctive therapy in adults with partial-onset seizures

1 reference

12 December 2020

Pharmacokinetics of levetiracetam during pregnancy, delivery, in the neonatal period, and lactation

1 reference

12 December 2020

The SANAD study of effectiveness of valproate, lamotrigine, or topiramate for generalised and unclassifiable epilepsy: an unblinded randomised controlled trial

1 reference

12 December 2020

Bone mineral density in children, adolescents, and young adults with epilepsy

1 reference

12 December 2020

Rufinamide for generalized seizures associated with Lennox-Gastaut syndrome

1 reference

12 December 2020

Adjunctive lacosamide for partial-onset seizures: Efficacy and safety results from a randomized controlled trial

1 reference

12 December 2020

Genetic basis for idiosyncratic reactions to antiepileptic drugs

1 reference

12 December 2020

Oral Contraceptives Induce Lamotrigine Metabolism: Evidence from a Double-blind, Placebo-controlled Trial

1 reference

12 December 2020

Management issues for women with epilepsy-Focus on pregnancy (an evidence-based review): I. Obstetrical complications and change in seizure frequency: Report of the Quality Standards Subcommittee and Therapeutics and Technology Assessment Subcommitt

1 reference

12 December 2020

Epilepsy and pregnancy

1 reference

12 December 2020

The FDA alert on suicidality and antiepileptic drugs: Fire or false alarm?

1 reference

12 December 2020

New onset geriatric epilepsy: a randomized study of gabapentin, lamotrigine, and carbamazepine

1 reference

12 December 2020

Pyridoxine supplementation for the treatment of levetiracetam-induced behavior side effects in children: preliminary results

1 reference

12 December 2020

Steady-state pharmacokinetics of lamotrigine when converting from a twice-daily immediate-release to a once-daily extended-release formulation in subjects with epilepsy (The COMPASS Study).

1 reference

12 December 2020

Management issues for women with epilepsy--focus on pregnancy (an evidence-based review): III. Vitamin K, folic acid, blood levels, and breast-feeding: Report of the Quality Standards Subcommittee and Therapeutics and Technology Assessment Subcommit

1 reference

12 December 2020

Antiepileptic drugs--best practice guidelines for therapeutic drug monitoring: a position paper by the subcommission on therapeutic drug monitoring, ILAE Commission on Therapeutic Strategies

1 reference

12 December 2020

Debate: Substitution of generic drugs in epilepsy: is there cause for concern?

1 reference

12 December 2020

ILAE treatment guidelines: evidence-based analysis of antiepileptic drug efficacy and effectiveness as initial monotherapy for epileptic seizures and syndromes

1 reference

12 December 2020

Management issues for women with epilepsy-Focus on pregnancy (an evidence-based review): II. Teratogenesis and perinatal outcomes: Report of the Quality Standards Subcommittee and Therapeutics and Technology Subcommittee of the American Academy of N

1 reference

12 December 2020

Epilepsy after the first drug fails: substitution or add-on?

1 reference

12 December 2020

The new antiepileptic drugs: scientific review

1 reference

12 December 2020

Suicidality, depression screening, and antiepileptic drugs: reaction to the FDA alert

1 reference

12 December 2020

Affect of Seizures During Gestation on Pregnancy Outcomes in Women With Epilepsy

1 reference

12 December 2020

10.1007/S11910-010-0120-8

Identifiers

DOI

1 reference

22 August 2017

1 reference